Royalty Pharma plc (RPRX)
After hours:
| Previous close | 28.68 |
| Open | 28.79 |
| Bid | 28.77 x 300 |
| Ask | 28.81 x 200 |
| Day's range | 28.69 - 29.07 |
| 52-week range | 25.20 - 31.66 |
| Volume | |
| Avg. volume | 2,660,598 |
| Market cap | 17.2B |
| Beta (5Y monthly) | 0.46 |
| PE ratio (TTM) | 16.17 |
| EPS (TTM) | 1.78 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | 0.84 (2.93%) |
| Ex-dividend date | 16 Aug 2024 |
| 1y target est | 44.83 |
GlobeNewswireRoyalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Molly Sawaya as Executive Vice President, Head of Human Capital. Molly joins Royalty Pharma from Hudson Bay Capital, where she was a Managing Director and Head of Colleague Experience, responsible for designing and delivering the firm’s Human Resources (HR) agenda, including onboarding, colleague engagement, professional development, compensation and benefits. Previously, Molly held a
Simply Wall St.Royalty Pharma (NASDAQ:RPRX) Is Due To Pay A Dividend Of $0.21
Royalty Pharma plc ( NASDAQ:RPRX ) has announced that it will pay a dividend of $0.21 per share on the 13th of...
- GlobeNewswire
Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day. Conference Call Information Please visit the “Investors” page of the company’s website at https://www.royaltypharma.com/investors/events/ to obtain conference call information
